These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 2283971)

  • 1. [IgG therapy of experimental E. coli sepsis in neutropenic mice].
    Dökmetaş I; Doğanay M; Bakir M
    Mikrobiyol Bul; 1990 Jul; 24(3):205-13. PubMed ID: 2283971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibiotic and specific immunoglobulin G in the treatment of E. coli sepsis in mice previously given steroids].
    Bakir M; Doğanay M; Dökmetaş I
    Mikrobiyol Bul; 1990 Oct; 24(4):336-43. PubMed ID: 2287291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
    Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
    Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
    Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantitative study of the antibacterial effect of cefotaxime and ceftriaxone during experimental Escherichia coli K1 bacteremia in chickens].
    Labarthe JC; Guillot JF; Mouline C; Bree A
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):664-7. PubMed ID: 2677929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of immunization dose schemes on immunoprotective response to recombinant signaling protein 14-3-3 of Schistosoma japonicum].
    Liu QZ; Hu YS; Shen JL; Jiang BL; Wang XL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jul; 40(4):248-52. PubMed ID: 17097003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticore endotoxin F(ab')2 equine immunoglobulin fragments protect against lethal effects of gram-negative bacterial sepsis.
    Dunn DL; Mach PA; Condie RM; Cerra FB
    Surgery; 1984 Aug; 96(2):440-6. PubMed ID: 6379963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte transfusions in recovery of neutropenic rats from induced E. coli toxicemia.
    Popovic V; Schaffer R; Popovic P
    Exp Hematol; 1977 May; 5(3):166-70. PubMed ID: 326570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The histopathological effects of different treatments on lung tissue of mice pretreated with cyclophosphamide and steroids in experimental E. coli sepsis].
    Düzcan E; Bakir M; Dökmetaş I; Doğanay M; Güneş H
    Mikrobiyol Bul; 1991 Oct; 25(4):349-59. PubMed ID: 1795659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein].
    Zhang Y; Lu SQ; Zhang YZ; Zhao BX; Xu JG
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):58-62. PubMed ID: 14990161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice.
    Yrjänäinen H; Hytönen J; Song XY; Oksi J; Hartiala K; Viljanen MK
    J Infect Dis; 2007 May; 195(10):1489-96. PubMed ID: 17436229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of in-vitro induced filaments, spheroplasts and rod-shaped bacteria in neutropenic mice.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    Clin Microbiol Infect; 2006 Nov; 12(11):1105-11. PubMed ID: 17002610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of amikacin dosing regimens in neutropenic guinea pigs with Escherichia coli infection.
    McClure JT; Rosin E
    Am J Vet Res; 1998 Jun; 59(6):750-5. PubMed ID: 9622746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Paganini H; Gómez S; Ruvinsky S; Zubizarreta P; Latella A; Fraquelli L; Iturres AS; Casimir L; Debbag R
    Cancer; 2003 Apr; 97(7):1775-80. PubMed ID: 12655535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empirical antibiotic therapy in febrile neutropenic patients with single-daily dose amikacin plus ceftriaxone.
    Suwangool P; Aswapokee N; Sathapatayavongs B; Leelasuphasri S; Siritanaratkul N; Chuncharunee S; Chayakul P
    J Med Assoc Thai; 1993 Jun; 76(6):314-8. PubMed ID: 8083623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone versus ceftazidime plus aminoglycoside therapy for infections in patients with neutropenia after cytotoxic chemotherapy. Short communication.
    Krcméry V; Danisovicová A; Drgona L; Spánik S; Fuchsberger P; Korec S; Svec J
    Neoplasma; 1993; 40(2):103-5. PubMed ID: 8350953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections.
    Meinen JB; McClure JT; Rosin E
    Am J Vet Res; 1995 Sep; 56(9):1219-24. PubMed ID: 7486402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG; Woods GL; Jiang Q; Gesser RM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.